Concepedia

Author

Floyd E. Fox

University of Pennsylvania

Also Known As

F E Fox, F Fox, F. E. Fox, F. Fox, F.E. Fox, FLOYD E. FOX, FLOYD FOX, Floyd E Fox, Floyd E. Fox, Floyd Fox

77

Publications

2.5K

Citations

24

H-Index

55

Concepts

All Affiliations

University of PennsylvaniaThe Wistar InstituteThe University of Texas MD Anderson Cancer CenterDuke UniversityFox Chase Cancer Center
FE

About

Floyd E. Fox is an author at University of Pennsylvania specializing in immunology, medicine, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

17

23

827

2

Cell Biology

6

6

306

3

Health Sciences

3

3

56

4

Allergy

3

3

131

5

Biochemistry

1

1

68

Floyd E. Fox

×

34

Publications

2.3K

Citations

23

H-Index

YearCitations

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G<sub>1</sub> Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2

Jennifer L. Spratlin, Roger B. Cohen, Matthew Eadens,

Journal of Clinical Oncology

2010

551

Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: A 10-year experience at a single institution

Scott Gottlieb, Jonathan Wolfe, Floyd E. Fox,

Journal of the American Academy of Dermatology

1996

213

Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.

U Rodeck, Aaron Bossler, Ullrich Graeven,

PubMed

1994

125

A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma.

James Posey, Thian C. Ng, Baolian Yang,

PubMed

2003

121

Regulation of cytokine expression in macrophages and the Langerhans cell-like line XS52 by calcitonin gene-related peptide

Hideshi Torii, Junichi Hosoi, Stefan Beissert,

Journal of Leukocyte Biology

1997

121

Calcitonin Gene-Related Peptide Inhibits Proliferation and Antigen Presentation by Human Peripheral Blood Mononuclear Cells: Effects on B7, Interleukin 10, and Interleukin12

Floyd E. Fox, Marek Kubin, Maureen Cassin,

Journal of Investigative Dermatology

1997

115

A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG1 Monoclonal Antibody Directed Against EGFR in Patients with Advanced Solid Malignancies

Bart C. Kuenen, Petronella O. Witteveen, Rita Ruijter,

Clinical Cancer Research

2010

86

A phase I, first in man study of weekly IMC-A12, a fully human insulin like growth factor-I receptor IgG1 monoclonal antibody, in patients with advanced solid tumors

Celestia S. Higano, E. Y. Yu, Samuel H. Whiting,

Journal of Clinical Oncology

2007

81

Phase I study of every 2- or 3-week dosing of ramucirumab, a human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2 in patients with advanced solid tumors

E. Gabriela Chiorean, Herbert I. Hurwitz, Roger B. Cohen,

Annals of Oncology

2015

79

Photoactivated Hypericin is an Anti-Proliferative Agent that Induces a High Rate of Apoptotic Death of Normal, Transformed, and Malignant T Lymphocytes: Implications for the Treatment of Cutaneous Lymphoproliferative and Inflammatory Disorders

Floyd E. Fox, Zhutian Niu, Alfonso J. Tobia,

Journal of Investigative Dermatology

1998

77

Page 1